おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cimeio Therapeutics
company
About
Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $50M
- Industries
- Biopharma,Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2020
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$50M
Cimeio Therapeutics has raised a total of
$50M
in funding over 2 rounds. Their latest funding was raised on
Apr 13, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 13, 2022 | Series A | $50M | 1 |
Versant Ventures
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
2
0
Cimeio Therapeutics has made 2 investments. Their most recent investment was on
Oct 12, 2021, when FrankieOne raised $20M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Oct 12, 2021
FrankieOne
|
Series A | $20M | Developer APIs | — |
|
Jul 28, 2021
Quansa
|
Seed | $3.58M | Employee Benefits | — |
Investors
Number of Lead Investors
Number of Investors
1
1
Cimeio Therapeutics is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Versant Ventures
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
